APA (7th ed.) Citation

J, C., AH, B., & H, F. (2025). Add-on combination therapy with monoclonal antibodies: Implications for drug development. The journal of prevention of Alzheimer's disease, 12(10), 100359. https://doi.org/10.1016/j.tjpad.2025.100359

Chicago Style (17th ed.) Citation

J, Cummings, Burstein AH, and Fillit H. "Add-on Combination Therapy with Monoclonal Antibodies: Implications for Drug Development." The Journal of Prevention of Alzheimer's Disease 12, no. 10 (2025): 100359. https://doi.org/10.1016/j.tjpad.2025.100359.

MLA (9th ed.) Citation

J, Cummings, et al. "Add-on Combination Therapy with Monoclonal Antibodies: Implications for Drug Development." The Journal of Prevention of Alzheimer's Disease, vol. 12, no. 10, 2025, p. 100359, https://doi.org/10.1016/j.tjpad.2025.100359.